Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
kyDxdhP0a3XGVU1w